Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascularized Composite Allotransplantation for Abdominal Wall Defects
NCT02416674Phase 1Unknown
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2015
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in abdominal wall defect, sponsored by Brigham and Women's Hospital. Primary endpoint: Allograft Survival at 5 years. Status: unknown.
02
Conditions
abdominal wall defect
Beyond the preview
Go deeper on NCT02416674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02416674.